Daclatasvir plus sofosbuvir ± ribavirin for the treatment of chronic hepatitis C
A review summarizes the results of clinical trials of daclatasvir plus sofosbuvir ± ribavirin in patienths with differ- ent genotypes of HCV (1, 2, 3 и 4).